Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:ABCN CVE:BCT NYSE:COV NYSE:EMC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABCNVIVO CannabisC$1.32+5.6%C$1.32C$0.80▼C$4.06C$256.62MN/A1.51 million shs310,601 shsBCTBriaCell TherapeuticsC$10.60-3.8%C$10.60C$3.50▼C$15.75C$168.68MN/A12,671 shs3,402 shsCOV(COV)$0.00$65.97▼$108.57N/AN/A3.88 million shsN/AEMCEMC$29.38+1.1%$0.00$22.99▼$29.13N/AN/A13.90 million shs6,010 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABCNVIVO Cannabis0.00%0.00%0.00%0.00%0.00%BCTBriaCell Therapeutics0.00%0.00%0.00%0.00%0.00%COV(COV)0.00%0.00%0.00%0.00%0.00%EMCEMC+0.20%+0.32%+3.33%+14.66%+4.47%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABCNVIVO CannabisN/AN/AN/AN/AN/AN/AN/AN/ABCTBriaCell TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACOV(COV)N/AN/AN/AN/AN/AN/AN/AN/AEMCEMCN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABCNVIVO Cannabis 0.00N/AN/AN/ABCTBriaCell Therapeutics 0.00N/AC$15.0041.51% UpsideCOV(COV) 0.00N/AN/AN/AEMCEMC 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABCNVIVO CannabisN/AN/AN/AN/AN/AN/ABCTBriaCell TherapeuticsN/AN/AC$3.34 per share3.17C$3.60 per shareN/ACOV(COV)N/AN/AN/AN/AN/AN/AEMCEMCN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABCNVIVO CannabisN/AN/A0.00∞N/AN/AN/AN/AN/ABCTBriaCell TherapeuticsN/A-C$0.38N/A∞N/AN/AN/AN/AN/ACOV(COV)N/AN/A0.00N/AN/AN/AN/AN/AN/AEMCEMCN/A$2.0514.33∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABCNVIVO CannabisN/AN/AN/AN/AN/ABCTBriaCell TherapeuticsN/AN/AN/AN/AN/ACOV(COV)N/AN/AN/AN/AN/AEMCEMC$0.461.57%N/A22.44%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABCNVIVO CannabisN/AN/AN/ABCTBriaCell Therapeutics0.05129.63128.68COV(COV)N/AN/AN/AEMCEMCN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABCNVIVO CannabisN/ABCTBriaCell TherapeuticsN/ACOV(COV)N/AEMCEMC79.86%Insider OwnershipCompanyInsider OwnershipABCNVIVO CannabisN/ABCTBriaCell TherapeuticsN/ACOV(COV)N/AEMCEMC0.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABCNVIVO CannabisN/A194.41 millionN/ANot OptionableBCTBriaCell Therapeutics515.91 millionN/ANot OptionableCOV(COV)N/AN/AN/ANot OptionableEMCEMCN/AN/AN/ANot OptionableCOV, ABCN, EMC, and BCT HeadlinesRecent News About These CompaniesWashington Youth Tour inspires Emma GebelJuly 15 at 12:55 AM | timesenterprise.comTFormer MSU Billings Chancellor Ron Sexton diesJuly 15 at 12:55 AM | billingsgazette.comBConexon Connect completes its largest fiber-to-the-home network to date, spanning 3,500 miles and reaching over 67,000 rural GeorgiansJuly 15 at 12:55 AM | finance.yahoo.comDiscovery Energy Metals Launches $1M Private Placement FinancingJuly 15 at 5:50 PM | tipranks.comEdgecombe-Martin EMC awards $1,000 scholarship to ECCJuly 10, 2025 | wnct.comWJoe Wheeler EMC announces temporary payment system downtimeJuly 9, 2025 | msn.comElectromechanical Cylinders for Heavy-Duty ApplicationsJuly 8, 2025 | machinedesign.comMWATCH IT: Walton EMC linemen who helped rebuild after Hurricane Katrina look back 20 years laterJuly 7, 2025 | onlineathens.comOJackson EMC Foundation awards $67K to agencies serving Gwinnett County residentsJuly 5, 2025 | gwinnettdailypost.comGCobb EMC considering term limit extensionJuly 4, 2025 | mdjonline.comMEMCOR Stock: What's Fueling The Rally?July 3, 2025 | benzinga.comNo Country Can Win War Without Electromagnetic Spectrum Control,' Says Ex-DRDO Scientist At Indore FDPJuly 3, 2025 | msn.comMany South Ga. residents without power following Tuesday stormsJuly 2, 2025 | msn.comSolar Farm to make its way to Newton CountyJuly 2, 2025 | covnews.comCCrews dispatched to Jones County to address power outagesJuly 2, 2025 | msn.comUganda: Bugerere Rally Returns to Kayunga With Boost for Local SchoolJuly 2, 2025 | msn.comGalaxy S26 could be getting not one, but two battery upgradesJuly 2, 2025 | androidauthority.comAOver 1,000 Albany residents without power following Tuesday stormsJuly 2, 2025 | msn.comGalaxy S26 Battery Getting Upgrades, But Not the One You WantJuly 2, 2025 | msn.comColombia suspends extradition of rebel leader wanted in the US for drug traffickingJuly 1, 2025 | msn.comNew MarketBeat Followers Over TimeTop HeadlinesView All Headlines3 Summer Short-Squeeze Candidates With Catalysts for CoveringBy Thomas Hughes | June 30, 2025View 3 Summer Short-Squeeze Candidates With Catalysts for CoveringBoeing's Rebound Is Well Underway—But Is It Too Late?By Leo Miller | July 10, 2025View Boeing's Rebound Is Well Underway—But Is It Too Late?3 Auto Chip Stocks Up 60%+ From 2025 Lows: More Gains Ahead?By Leo Miller | June 18, 2025View 3 Auto Chip Stocks Up 60%+ From 2025 Lows: More Gains Ahead?The Top 116 Small Businesses Americans Want to Fund With $10K [2025 Survey]By MarketBeat Staff | June 24, 2025View The Top 116 Small Businesses Americans Want to Fund With $10K [2025 Survey]2 Reasons to Buy Trade Desk Stock Now and 1 Warning SignBy Sam Quirke | July 1, 2025View 2 Reasons to Buy Trade Desk Stock Now and 1 Warning SignCOV, ABCN, EMC, and BCT Company DescriptionsVIVO Cannabis CVE:ABCNC$1.32 +0.07 (+5.60%) As of 08/3/2018ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.BriaCell Therapeutics CVE:BCTC$10.60 -0.42 (-3.81%) As of 12/30/2021BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.(COV) NYSE:COVCovidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.EMC NYSE:EMCEMC Corporation (EMC) develops, delivers and supports the information technology (IT) industry's range of information infrastructure and virtual infrastructure technologies, solutions and services. EMC manages the Company as part of a federation of businesses: EMC Information Infrastructure, VMware Virtual Infrastructure, Pivotal and Virtustream. EMC's Information Infrastructure business provides a foundation for organizations to store, manage, protect, analyze and secure information. EMC's VMware Virtual Infrastructure business is engaged in virtualization and cloud infrastructure solutions that enable businesses to help transform the way they build, deliver and consume IT resources in a manner that is based on their specific needs. EMC's Pivotal business unites strategic technology, people and programs from EMC and VMware and has a platform that consists of data, agile development practices and a cloud independent platform-as-a-service. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Delta Air Lines Stock Rallies on New Guidance—Can It Keep Going? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
